<?xml version="1.0" encoding="UTF-8"?>

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="Immunoterapi"/>
  <text>
    <status value="extensions"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet Immunoterapi</b></p><a name="Immunoterapi"> </a><a name="hcImmunoterapi"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href="CodeSystem-GenericValues.html"><code>https://kip.rkkp.dk/fhir/CodeSystem/GenericValues</code></a><span title="Version is not explicitly stated, which means it is fixed to the version provided in this specification"> version &#x1F4E6;2.13.0</span><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-GenericValues.html#GenericValues-none">none</a></td><td>Ingen immunoterapi</td><td>None - used to choose none of the available values</td></tr></table></li><li>Include these codes as defined in <a href="CodeSystem-ATC.html"><code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code></a><span title="Version is not explicitly stated, which means it is fixed to the version provided in this specification"> version &#x1F4E6;2.13.0</span><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FA01">L01FA01</a></td><td>Rituximab</td><td>L01FA01 - rituximab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FA03">L01FA03</a></td><td>Obinutuzumab</td><td>L01FA03 - obinutuzumab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FA02">L01FA02</a></td><td>Ofatumumab</td><td>L01FA02 - ofatumumab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L04AA">L04AA</a></td><td>MabCampath</td><td>L04AA - Selective immunosuppressants</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FX05">L01FX05</a></td><td>Brentuximab Vedotin (Adcetris)</td><td>L01FX05 - brentuximab vedotin</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FX14">L01FX14</a></td><td>Polatuzumab Incl evt. Rituximab</td><td>L01FX14 - polatuzumab vedotin</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FF">L01FF</a></td><td>PD(L)1 hæmmere</td><td>L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors</td></tr></table></li><li>Include these codes as defined in <a href="CodeSystem-TreatmentUnspecified.html"><code>https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified</code></a><span title="Version is not explicitly stated, which means it is fixed to the version provided in this specification"> version &#x1F4E6;2.13.0</span><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-TreatmentUnspecified.html#TreatmentUnspecified-glofitamab">glofitamab</a></td><td>Bispecifikke el Epcoritamab Incl evt. Rituximab</td><td>Glofitamab</td></tr><tr><td><a href="CodeSystem-TreatmentUnspecified.html#TreatmentUnspecified-Polatuzumab">Polatuzumab</a></td><td>Bispecifikke + Polatuzumab Incl evt. Rituximab</td><td>Bispecifikke+Polatuzumab Incl evt. Rituximab</td></tr></table></li></ul></div>
  </text>
  <url value="https://kip.rkkp.dk/fhir/ValueSet/Immunoterapi"/>
  <version value="2.13.0"/>
  <name value="Immunoterapi"/>
  <title value="Immunoterapi"/>
  <status value="active"/>
  <experimental value="true"/>
  <date value="2022-07-18T00:00:00+02:00"/>
  <publisher value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
  <contact>
    <name value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
    <telecom>
      <system value="url"/>
      <value value="https://trifork.com"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="rbk@trifork.com"/>
    </telecom>
  </contact>
  <description value="Immunoterapi"/>
  <compose>
    <include>
      <system value="https://kip.rkkp.dk/fhir/CodeSystem/GenericValues"/>
      <concept>
        <code value="none"/>
        <display value="Ingen immunoterapi"/>
      </concept>
    </include>
    <include>
      <system value="https://kip.rkkp.dk/fhir/CodeSystem/ATC"/>
      <concept>
        <code value="L01FA01"/>
        <display value="Rituximab"/>
      </concept>
      <concept>
        <code value="L01FA03"/>
        <display value="Obinutuzumab"/>
      </concept>
      <concept>
        <code value="L01FA02"/>
        <display value="Ofatumumab"/>
      </concept>
      <concept>
        <code value="L04AA"/>
        <display value="MabCampath"/>
      </concept>
      <concept>
        <code value="L01FX05"/>
        <display value="Brentuximab Vedotin (Adcetris)"/>
      </concept>
      <concept>
        <code value="L01FX14"/>
        <display value="Polatuzumab Incl evt. Rituximab"/>
      </concept>
      <concept>
        <code value="L01FF"/>
        <display value="PD(L)1 hæmmere"/>
      </concept>
    </include>
    <include>
      <system value="https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified"/>
      <concept>
        <code value="glofitamab"/>
        <display value="Bispecifikke el Epcoritamab Incl evt. Rituximab"/>
      </concept>
      <concept>
        <code value="Polatuzumab"/>
        <display value="Bispecifikke + Polatuzumab Incl evt. Rituximab"/>
      </concept>
    </include>
  </compose>
</ValueSet>